Daniel Virnich, CEO: Starling Oncology STLN Buy · Filed 25/03/28

Trade details

Type: Insider buy
Amount: $23,545.6
Shares · price: 22,640 sh · $1.04 a share
Held after: 724,363 sh
Stock: Starling Oncology STLN
Person: Daniel VirnichCEO
Trade date: 25/03/26
Filed: 25/03/28
Days to filing: 2 days

First buy since 2023

Insiders buying this week: 8 insiders
Holding change: +3.2%

Starling Oncology trades, last 26 weeks

What else happened in Starling Oncology around then

Filed or reported within 30 days of the trade day · 25/02/24~25/04/25

Daniel Virnich's recent trades

No other trades yet.